Dr. Dessain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S 11th St
Ste 4240
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 215-955-2340
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
Yale School of MedicineClass of 1994
Certifications & Licensure
PA State Medical License 2002 - 2024- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2107 citationshSIR2SIRT1 Functions as an NAD-Dependent p53 DeacetylaseHomayoun Vaziri, Scott K. Dessain, Elinor Ng Eaton, Shin-ichiro Imai, Roy A. Frye
Cell. 2001-10-19 - 118 citationsTreatment of adenovirus disease in stem cell transplant recipients with cidofovir.Dionissios Neofytos, Ambrish Ojha, Bijoyesh Mookerjee, John E. Wagner, Joanne Filicko
Biology of Blood and Marrow Transplantation. 2007-01-01 - 239 citationsN-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastomaRené Bernards, Scott K. Dessain, Robert A. Weinberg
Cell. 1986-12-05
Press Mentions
InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine CharacterizationJuly 1st, 2021
Multiplexed, Microscale, Microarray-Based Serological Assay for Antibodies Against All Human-Relevant CoronavirusesFebruary 25th, 2021- Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19July 28th, 2020
- Join now to see all
Grant Support
- Human Monoclonal Antibodies That Bind Botulinum ToxinsNational Institute Of Allergy And Infectious Diseases2007–2012
- Human Monoclonal Antibodies That Bind Botulinum ToxinsNational Institute Of Allergy And Infectious Diseases2006–2007
- Progression Of Chronic Myelogenous LeukemiaNational Heart, Lung, And Blood Institute2002–2004
- Progression Of Chronic Myelogenous LeukemiaNational Heart, Lung, And Blood Institute2000–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
